🔍
Search Results - ratish+gambhira
2
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Hybridoma expressing anti-RG-1 mAb for the study of human papillomavirus L2
Technology DescriptionJHU scientists generated a hybridoma expressing a monoclonal antibody, RG-1, that binds to highly conserved L2 residues and neutralizes human papillomavirus 16 (HPV16) and HPV18. Passive immunotherapy with RG-1 was protective in mice. Antiserum to the HPV16 L2 peptide comprising conserved residues neutralized pseudoviruses HPV5,...
Published: 3/13/2025
|
Inventor(s):
Ratish Gambhira
,
Richard Roden
Keywords(s):
Antibodies
,
Basic Research Biomarker
,
Cell Model
,
Discovery/Research Tools
,
Hybridomas
,
In Vitro Research Tool
,
Monoclonal Antibodies
,
Research Reagent
Category(s):
Technology Classifications > Research Tools > Antibodies
,
Technology Classifications > Research Tools > Cell Lines
,
Technology Classifications > Research Tools
Unexpected Cross-neutralization of Cutaneous & Mucosal Papillomavirus Types with Anti-Sera to a Novel L2 Epitopes
C04603: Unexpected Cross-neutralization of Cutaneous & Mucosal Papillomavirus Types with Anti-Sera to a Novel Epitopes Technical Details: High risk Human Papillomavirus (HPV) infection is a common cause of cervical cancer. Researchers at JHU have found that vaccination with the N terminus of HPV16 and bovine papillomavirus 1 can induce cross...
Published: 3/13/2025
|
Inventor(s):
John Schiller
,
Douglas Lowy
,
Diane Pastrana
,
Ratish Gambhira
,
Richard Roden
Keywords(s):
Biologics
,
Cancers
,
Cervical Cancer
,
Disease Indication
,
Human Papillomavirus (HPV)
,
Infectious Diseases
,
Therapeutic Matter
,
Therapeutic Substance
,
Therapeutics
,
Vaccine
Category(s):
Clinical and Disease Specializations
,
Clinical and Disease Specializations > Oncology > Cervical Cancer
,
Clinical and Disease Specializations > Women's Health
,
Technology Classifications > Therapeutic Modalities > Biologics
,
Technology Classifications > Therapeutic Modalities > Vaccines
,
Clinical and Disease Specializations > Oncology
,
Technology Classifications > Therapeutic Modalities
,
Clinical and Disease Specializations > Infectious Diseases > Human Papillomavirus (HPV)
JHTV Home
|
Search
|
Login/Subscribe
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by
Inteum